Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis

Ling Ma, Xiaoli Chen, Mohammed Ali Ali Aziz, Aijun Chen, Tao Cai, Shuang Chen Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Tao Cai, Department of Dermatology, The First Affiliated Hospital of Chongqing...

Full description

Saved in:
Bibliographic Details
Main Authors: Ma L, Chen X, Aziz MAA, Chen A, Cai T, Chen S
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Psoriasis: Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/dual-biologic-therapy-for-psoriasis-in-a-patient-with-atopic-dermatiti-peer-reviewed-fulltext-article-PTT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170763016929280
author Ma L
Chen X
Aziz MAA
Chen A
Cai T
Chen S
author_facet Ma L
Chen X
Aziz MAA
Chen A
Cai T
Chen S
author_sort Ma L
collection DOAJ
description Ling Ma, Xiaoli Chen, Mohammed Ali Ali Aziz, Aijun Chen, Tao Cai, Shuang Chen Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Tao Cai, Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, People’s Republic of China, Email 15902305525@163.com Shuang Chen, Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, People’s Republic of China, Email shuangchen07@hotmail.comAbstract: Psoriasis and atopic dermatitis (AD), once viewed as mutually exclusive diseases, are increasingly recognized to co-occur in complex inflammatory phenotypes. We present a 17-year-old male with multimorbid atopic conditions, including persistent atopic dermatitis, allergic rhinitis, and asthma, who developed new-onset psoriasis in the absence of previous biologic therapy. Initially misdiagnosed as exacerbated AD, he received ineffective treatment for one year. Treatment with secukinumab yielded limited improvement in psoriatic symptoms and eczematous lesions. AD and psoriasis significantly improved after adding dupilumab for 12 weeks; there were no documented side effects and a durable remission lasting 78 weeks. This case report underscores the importance of vigilance in patients with long-standing AD for newly emerging psoriasis and cautions against attributing all new rashes solely to chronic AD history. This case highlights the potential benefit of dual biologic therapy in managing concurrent type 2 inflammatory diseases and psoriasis, suggesting that a comprehensive immune-modulatory approach may be advantageous for patients with these coexisting conditions.Keywords: dupilumab, secukinumab, psoriasis, atopic dermatitis, dual biologic therapy
format Article
id doaj-art-c9df4a28fbd5408eabf4a7cd95066eb8
institution OA Journals
issn 2230-326X
language English
publishDate 2025-04-01
publisher Dove Medical Press
record_format Article
series Psoriasis: Targets and Therapy
spelling doaj-art-c9df4a28fbd5408eabf4a7cd95066eb82025-08-20T02:20:25ZengDove Medical PressPsoriasis: Targets and Therapy2230-326X2025-04-01Volume 15159161102326Dual Biologic Therapy for Psoriasis in a Patient with Atopic DermatitisMa LChen XAziz MAAChen ACai TChen SLing Ma, Xiaoli Chen, Mohammed Ali Ali Aziz, Aijun Chen, Tao Cai, Shuang Chen Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Tao Cai, Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, People’s Republic of China, Email 15902305525@163.com Shuang Chen, Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, People’s Republic of China, Email shuangchen07@hotmail.comAbstract: Psoriasis and atopic dermatitis (AD), once viewed as mutually exclusive diseases, are increasingly recognized to co-occur in complex inflammatory phenotypes. We present a 17-year-old male with multimorbid atopic conditions, including persistent atopic dermatitis, allergic rhinitis, and asthma, who developed new-onset psoriasis in the absence of previous biologic therapy. Initially misdiagnosed as exacerbated AD, he received ineffective treatment for one year. Treatment with secukinumab yielded limited improvement in psoriatic symptoms and eczematous lesions. AD and psoriasis significantly improved after adding dupilumab for 12 weeks; there were no documented side effects and a durable remission lasting 78 weeks. This case report underscores the importance of vigilance in patients with long-standing AD for newly emerging psoriasis and cautions against attributing all new rashes solely to chronic AD history. This case highlights the potential benefit of dual biologic therapy in managing concurrent type 2 inflammatory diseases and psoriasis, suggesting that a comprehensive immune-modulatory approach may be advantageous for patients with these coexisting conditions.Keywords: dupilumab, secukinumab, psoriasis, atopic dermatitis, dual biologic therapyhttps://www.dovepress.com/dual-biologic-therapy-for-psoriasis-in-a-patient-with-atopic-dermatiti-peer-reviewed-fulltext-article-PTTdupilumabsecukinumabpsoriasisatopic dermatitisdual biologic therapy
spellingShingle Ma L
Chen X
Aziz MAA
Chen A
Cai T
Chen S
Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
Psoriasis: Targets and Therapy
dupilumab
secukinumab
psoriasis
atopic dermatitis
dual biologic therapy
title Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
title_full Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
title_fullStr Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
title_full_unstemmed Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
title_short Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
title_sort dual biologic therapy for psoriasis in a patient with atopic dermatitis
topic dupilumab
secukinumab
psoriasis
atopic dermatitis
dual biologic therapy
url https://www.dovepress.com/dual-biologic-therapy-for-psoriasis-in-a-patient-with-atopic-dermatiti-peer-reviewed-fulltext-article-PTT
work_keys_str_mv AT mal dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis
AT chenx dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis
AT azizmaa dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis
AT chena dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis
AT cait dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis
AT chens dualbiologictherapyforpsoriasisinapatientwithatopicdermatitis